Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis

References

• Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051–2058.
   PubMed Web of Science ®Google Scholar
• Andratschke N, Alheid H, Allgauer M, et al. The SBRT database initiative of the german society for radiation oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer. 2018;18(1):283.
   PubMed Web of Science ®Google Scholar
• Clerici E, Comito T, Franzese C, et al. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors. Strahlenther Onkol. 2020;196(4):325–333.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Baus WW, Blanck O, et al. Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol. 2020;196(5):417–420.
   PubMed Web of Science ®Google Scholar
• Schmitt D, Blanck O, Gauer T, et al. Technological quality requirements for stereotactic radiotherapy: expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol. 2020;196(5):421–443.
   PubMed Web of Science ®Google Scholar
• Bae SH, Park HC, Yoon WS, et al. Treatment outcome after fractionated conformal radiotherapy for hepatocellular carcinoma in patients with child-pugh classification B in korea (KROG 16-05). Cancer Res Treat. 2019;51(4):1589–1599.
   PubMed Web of Science ®Google Scholar
• Hsieh CE, Venkatesulu BP, Lee CH, et al. Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy. Int J Radiat Oncol Biol Phys. 2019;105(1):73–86.
   PubMed Web of Science ®Google Scholar
• Rim CH, Kim HJ, Seong J. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies. Radiother Oncol. 2019;131:135–144.
   PubMed Web of Science ®Google Scholar
• Nabavizadeh N, Waller JG, Fain R, 3rd, et al. Safety and efficacy of accelerated hypofractionation and stereotactic body radiation therapy for hepatocellular carcinoma patients with varying degrees of hepatic impairment. Int J Radiat Oncol Biol Phys. 2018;100(3):577–585.
   PubMed Web of Science ®Google Scholar
• Boda-Heggemann J, Jahnke A, Chan MKH, et al. Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT. Strahlenther Onkol. 2018;194(5):414–424.
   PubMed Web of Science ®Google Scholar
• Sihono DSK, Vogel L, Weiß C, et al. A 4D ultrasound real-time tracking system for external beam radiotherapy of upper abdominal lesions under breath-hold. Strahlenther Onkol. 2017;193(3):213–220.
   PubMed Web of Science ®Google Scholar
• Vogel L, Sihono DSK, Weiss C, et al. Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: an estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT. Radiother Oncol. 2018;129(3):441–448.
   PubMed Web of Science ®Google Scholar
• Boda-Heggemann J, Attenberger U, Budjan J, et al. MRI morphologic alterations after liver SBRT: direct dose correlation with intermodal matching. Strahlenther Onkol. 2016;192(9):641–648. Sep
   PubMed Web of Science ®Google Scholar
• Andratschke N, Parys A, Stadtfeld S, et al. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases. Radiat Oncol. 2016;11:74.
   PubMed Web of Science ®Google Scholar
• Mahadevan A, Blanck O, Lanciano R, et al. Stereotactic body radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch(R) Patient registry. Radiat Oncol. 2018;13(1):26.
   PubMedGoogle Scholar
• Boda-Heggemann J, Jahnke A, Chan MKH, et al. In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations. Radiother Oncol. 2019;134:158–165.
   PubMed Web of Science ®Google Scholar
• Koay EJ, Owen D, Das P. Radiation-induced liver disease and modern radiotherapy. Semin Radiat Oncol. 2018;28(4):321–331.
   PubMed Web of Science ®Google Scholar
• Son SH, Choi BO, Ryu MR, et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys. 2010;78(4):1073–1080.
   PubMed Web of Science ®Google Scholar
• Stera S, Miebach G, Buergy D, et al. Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: an outcome analysis of a pooled multi-platform patient cohort. Radiother Oncol. 2021;158:230–236.
   PubMed Web of Science ®Google Scholar
• Olsen CC, Welsh J, Kavanagh BD, et al. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy [case reports clinical trial, phase I clinical trial, phase II]. Int J Radiat Oncol Biol Phys. 2009;73(5):1414–1424.
   PubMed Web of Science ®Google Scholar
• Stinauer MA, Diot Q, Westerly DC, et al. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys. 2012;83(5):e613–8.
   PubMed Web of Science ®Google Scholar
• Dreher C, Hoyer KI, Fode MM, et al. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma. Acta Oncol. 2016;55(7):886–891.
   PubMed Web of Science ®Google Scholar
• Gkika E, Strouthos I, Kirste S, et al. Repeated SBRT for in- and out-of-field recurrences in the liver. Strahlenther Onkol. 2019;195(3):246–253.
   PubMed Web of Science ®Google Scholar
• Sterzing F, Brunner TB, Ernst I, et al. Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on stereotactic radiotherapy. Strahlenther Onkol. 2014;190(10):872–881.
   PubMed Web of Science ®Google Scholar
• Dreher C, Linde P, Boda-Heggemann J, et al. Radiomics for liver tumours. Strahlenther Onkol. 2020;196(10):888–899.
   PubMed Web of Science ®Google Scholar
• Herfarth KK, Hof H, Bahner ML, et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Rad Oncol Biol Phys. 2003;57(2):444–451.
   PubMed Web of Science ®Google Scholar
• Hussein M, Akintonde A, McClelland J, et al. Clinical use, challenges, and barriers to implementation of deformable image registration in radiotherapy – the need for guidance and QA tools. Br J Radiol. 2021;94(1122):20210001.
   PubMed Web of Science ®Google Scholar
• Lowther N, Louwe R, Yuen J, et al. MIRSIG position paper: the use of image registration and fusion algorithms in radiotherapy. Phys Eng Sci Med. 2022;45(2):421–428.
   PubMedGoogle Scholar